| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Journal of Applied Physiology, Vol 77, Issue 5 2366-2373, Copyright © 1994 by American Physiological Society
ARTICLES |
P. Q. Eichacker, Y. Waisman, C. Natanson, A. Farese, W. D. Hoffman, S. M. Banks and T. J. MacVittie
Armed Forces Radiobiology Research Institute, Defense Nuclear Agency, Bethesda 20814.
We investigated the effects of recombinant granulocyte colony-stimulating factor (G-CSF) in a canine model of septic shock. Awake 2-yr-old beagles were studied before and after intraperitoneal placement of an Escherichia coli-infected clot. Nine days before and until 3 days after clot placement, animals received daily high-dose (G-CSF (5 microgram/kg body wt; n = 17), low-dose G-CSF (0.1 microgram/kg body wt; n = 17), or a control protein (5 micrograms/kg body wt; n = 20). Survival rate was greater (P < 0.04, Wilcoxon test) in the high-dose G-CSF group (14/17) than in the low-dose G-CSF (10/17) and control (12/20) groups. High-dose G-CSF improved cardiovascular function, as evidenced by increased left ventricular ejection fraction (day 1 after clot; P < 0.001) and mean arterial pressure (day 2; P < 0.02) compared with low-dose G-CSF and control groups. High-dose G-CSF increased (P < 0.001) mean peripheral neutrophils before (-3 days) and after (2 h to 4 days) clot and produced a more rapid (P < 0.001) rise (day 2) and fall (day 4) in mean alveolar neutrophil numbers compared with the low-dose G-CSF and control groups. High-dose G-CSF decreased mean serum endotoxin (2-8 h; P < 0.002) and tumor necrosis factor (2 h; P < 0.02) levels and lowered blood bacteria counts (2-6 h; P < 0.04) compared with the low-dose G-CSF and control groups. Thus, in this canine model, G-CSF sufficient to increase peripheral neutrophils before and during peritonitis and septic shock enhances host defense, reduces cytokine (tumor necrosis factor) levels, and improves cardiovascular function and survival.
This article has been cited by other articles:
|
|
 |
|
  G. Matute-Bello, C. W. Frevert, and T. R. Martin Animal models of acute lung injury Am J Physiol Lung Cell Mol Physiol, September 1, 2008; 295(3): L379 - L399. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. C. Minneci, K. J. Deans, B. Hansen, C. Parent, C. Romines, D. A. Gonzales, S.-X. Ying, P. Munson, A. F. Suffredini, J. Feng, et al. A canine model of septic shock: balancing animal welfare and scientific relevance Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2487 - H2500. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Quezado, C. Parent, W. Karzai, M. Depietro, C. Natanson, W. Hammond, R. L. Danner, X. Cui, Y. Fitz, S. M. Banks, et al. Acute G-CSF therapy is not protective during lethal E. coli sepsis Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2001; 281(4): R1177 - R1185. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Zhang, G. J. Bagby, J. K. Kolls, D. A. Welsh, W. R. Summer, J. Andresen, and S. Nelson The Effects of Granulocyte Colony-Stimulating Factor and Neutrophil Recruitment on the Pulmonary Chemokine Response to Intratracheal Endotoxin J. Immunol., January 1, 2001; 166(1): 458 - 465. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Rodgers, S. Xiong, T. Espinoza, N. Roda, S. Maldonado, and G. S. diZerega Angiotensin II Increases Host Resistance to Peritonitis Clin. Vaccine Immunol., July 1, 2000; 7(4): 635 - 640. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. KARZAI, B. U. von SPECHT, C. PARENT, J. HABERSTROH, K. WOLLERSEN, C. NATANSON, S. M. BANKS, and PETER. Q. EICHACKER G-CSF during Escherichia coli versus Staphylococcus aureus Pneumonia in Rats Has Fundamentally Different and Opposite Effects Am. J. Respir. Crit. Care Med., May 1, 1999; 159(5): 1377 - 1382. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Weiss, L. L. Moldawer, and E. M. Schneider Granulocyte Colony-Stimulating Factor to Prevent the Progression of Systemic Nonresponsiveness in Systemic Inflammatory Response Syndrome and Sepsis Blood, January 15, 1999; 93(2): 425 - 439. [Full Text] [PDF]
|
|
|
|
 |
|
 Z. M. N. Quezado, W. D. Hoffman, S. M. Banks, R. L. Danner, P. Q. Eichacker, G. M. Susla, and C. Natanson Increasing Doses of Pentoxifylline as a Continuous Infusion in Canine Septic Shock J. Pharmacol. Exp. Ther., January 1, 1999; 288(1): 107 - 113. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Nadai, I. Matsuda, L. Wang, A. Itoh, K. Naruhashi, T. Nabeshima, M. Asai, and T. Hasegawa Granulocyte Colony-Stimulating Factor Enhances Endotoxin-Induced Decrease in Biliary Excretion of the Antibiotic Cefoperazone in Rats Antimicrob. Agents Chemother., September 1, 1998; 42(9): 2178 - 2183. [Abstract] [Full Text]
|
|
|
|
 |
|
 B. D. Freeman, Z. Quezado, F. Zeni, C. Natanson, R. L. Danner, S. Banks, M. Quezado, Y. Fitz, J. Bacher, and P. Q. Eichacker rG-CSF reduces endotoxemia and improves survival during E. coli pneumonia J Appl Physiol, November 1, 1997; 83(5): 1467 - 1475. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
